Trademark: 88319644
Word
ENTHYMIC
Status
Registered
Status Code
700
Status Date
Tuesday, March 10, 2020
Serial Number
88319644
Registration Number
6005358
Registration Date
Tuesday, March 10, 2020
Mark Type
4000
Filing Date
Thursday, February 28, 2019
Published for Opposition
Tuesday, December 24, 2019

Trademark Owner History
Enzyvant Therapeutics GmbH - Original Registrant

Classifications
5 Pharmaceutical preparations for human use for the treatment of pediatric congenital athymia and thymus gland diseases, disorders and conditions, and immune deficiency related thereto; pharmaceutical preparations for human use, namely, tissue-based regenerative therapy to treat pediatric congenital athymia and thymus gland diseases, disorders and conditions, and immune deficiency related thereto; biologic preparations for medical and therapeutic purposes for the treatment of pediatric congenital athymia and thymus gland diseases, disorders and conditions, and immune deficiency related thereto; biologic preparations for medical and therapeutic purposes, namely, tissue-based regenerative therapy to treat pediatric congenital athymia and thymus gland diseases, disorders and conditions, and immune deficiency related thereto

Trademark Events
Mar 10, 2020
Registered-Principal Register
Dec 24, 2019
Official Gazette Publication Confirmation E-Mailed
Dec 24, 2019
Published For Opposition
Dec 4, 2019
Notification Of Notice Of Publication E-Mailed
Nov 20, 2019
Assigned To Lie
Nov 16, 2019
Approved For Pub - Principal Register
Oct 18, 2019
Teas/Email Correspondence Entered
Oct 16, 2019
Correspondence Received In Law Office
Oct 16, 2019
Teas Response To Office Action Received
Jul 25, 2019
Assigned To Examiner
May 16, 2019
Notification Of Non-Final Action E-Mailed
May 16, 2019
Non-Final Action E-Mailed
May 16, 2019
Non-Final Action Written
May 9, 2019
Assigned To Examiner
Mar 19, 2019
New Application Office Supplied Data Entered In Tram
Mar 4, 2019
New Application Entered In Tram

Trademark Alertz updated from USPTO on 2030-01-24